التفاصيل البيبلوغرافية
العنوان: |
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial |
المؤلفون: |
Robert, Caroline, Ribas, Antoni, Wolchok, Jedd D, Hodi, F Stephen, Hamid, Omid, Kefford, Richard, Weber, Jeffrey S, Joshua, Anthony M, Hwu, Wen-Jen, Gangadhar, Tara C, Patnaik, Amita, Dronca, Roxana, Zarour, Hassane, Joseph, Richard W, Boasberg, Peter, Chmielowski, Bartosz, Mateus, Christine, Postow, Michael A, Gergich, Kevin, Elassaiss-Schaap, Jeroen, Li, Xiaoyun Nicole, Iannone, Robert, Ebbinghaus, Scot W, Kang, S Peter, Daud, Adil |
المصدر: |
The Lancet ; volume 384, issue 9948, page 1109-1117 ; ISSN 0140-6736 |
بيانات النشر: |
Elsevier BV |
سنة النشر: |
2014 |
المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: |
article in journal/newspaper |
اللغة: |
English |
DOI: |
10.1016/s0140-6736(14)60958-2 |
الإتاحة: |
https://doi.org/10.1016/s0140-6736Test(14)60958-2 https://api.elsevier.com/content/article/PII:S0140673614609582?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0140673614609582?httpAccept=text/plainTest |
حقوق: |
https://www.elsevier.com/tdm/userlicense/1.0Test/ |
رقم الانضمام: |
edsbas.1C22DB95 |
قاعدة البيانات: |
BASE |